/Investor DB

F-Prime Capital — 2021 Investments

18 investments dated 2021 · listed companies and verified rows first · show all

Caribou Biosciencescariboubio.comin𝕏NASDAQ: CRBUMar 2021

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform.

BiotechMedical DevicesBerkeley, US

Jennifer Doudna(Founder)Rachel Haurwitz(Founder)inMartin Jinek(Founder)Andrew May(Executive Officer)James Berger(Founder)

BoardJenny Rooke(Director)in

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAliment CapitalAvego BioScience CapitalIA Seed VenturesLifeSci Venture PartnersMission Bay CapitalMission Biocapital+3 more

Xilio Therapeuticsxiliotx.cominNASDAQ: XLOJan 2021

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsBain Capital Life SciencesBay City CapitalM VenturesMRL Ventures FundRA CapitalRiverVest Venture Partners+9 more

Leyden Labsleydenlabs.cominSeries A · Mar 2021 · $47M✓ verified

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsClavystBioGV (Google Ventures)Bluebird VenturesByers CapitalCasdin CapitalEuropean Innovation Council Fund+7 more

Snapdocssnapdocs.comin𝕏Seed · May 2021

Snapdocs automates the digital mortgage closing process by connecting lending, settlement, and secondary market teams.

AI & Machine LearningFintechLegalTechPropTechSaaSPortland, US

Aaron King(CEO)inMatt Schindel(Executive Officer)Sanam Pangali(Executive Officer)Michael Sachdev(CEO)inNeel Palrecha(Vice President Engineering)inPeter Clark(Head of Product)in

Board seatDavid Jegen· per SEC Form D

Co-investors137 VenturesAccelerator VenturesAlkeon InnovationMetaPropMetaProp VenturesRed Swan Ventures+20 more

Adelaadelabio.comin𝕏Series A · Jun 2021 · $60M

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier.

BiotechDigital HealthHealthtechMedical DevicesFoster City, US

Daniel Diniz De Carvalho(Executive Officer, Promoter)Scott Bratman(Executive Officer, Director)inAnne-Renee Hartman(Founder)inAlan Williams(Executive Officer)inLisa Alderson(Executive Officer, Director)inPriscilla Huang(Executive Officer)in

Co-investorsDecheng CapitalOrbiMedDeerfield Management CompanyMenlo Ventures

AppliedVRappliedvr.ioin𝕏Series A · Mar 2021 · $29M

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

Matthew Stoudt(Co-Founder and CEO)inJosh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsEntrada VenturesJAZZ Venture PartnersMagnetic VenturesPresence CapitalTechstarsGSR Ventures+1 more

Atalantaatalantatx.comin𝕏Series A · Jan 2021 · $110M

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsNovartis Venture FundRiverVest Venture PartnersSanofi Venturesabrdn plcEQT Life Sciences

Carestackcarestack.comin𝕏Apr 2021 · $25M

CareStack is a cloud-based, all-in-one dental practice management software covering scheduling, patient experience, clinical workflows, revenue cycle management, analytics, and compliance.

Digital HealthHealthtechSaaS

Abhi Krishna(Founder)Abhilash Krishna(Founder)Abilash Krishna(Founder)Kevin Cook(Founder)Mark Huzyak(Founder)Varun Nelson(Founder)

Co-investorsAccelCallapina CapitalEight Roads VenturesSteadview Capital

Castorcastoredc.cominSeries B · Jul 2021 · $45MDefunct

Castor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSTel Aviv, IL

Derk Arts(Founder)in

Co-investorsAsahi Kasei Corporate Venture CapitalInkefTechstarsChartered GroupTwo Sigma Ventures

Honehonehq.comin𝕏Nov 2021

Hone provides an AI-powered platform delivering live training and continuous learning experiences for organizations, covering skills development from leadership and communication to performance management.

AI & Machine LearningEdTechEnterprise SoftwareHR Tech

Tom(Co-founder & CEO)inSavina(Co-founder)inTom Griffiths(Founder)inSavina Perez(Founder)

Co-investorsCowboy VenturesGaingelsMana VenturesNextGen Venture PartnersSemperVirens Venture CapitalSwift Ventures+6 more

Hurdlehurdle.bioJan 2021 · $5M

Hurdle provides diagnostic testing infrastructure for healthcare partners, including sample collection kits, lab network access, fulfillment services, and biomarker R&D capabilities across the UK and EU.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investors.406 VenturesSamos InvestmentsSOSVStart CapitalSeae VenturesStartUp Health

nocdtreatmyocd.comin𝕏Series B · Sep 2021 · $33M

NOCD provides specialized treatment for obsessive-compulsive disorder through live video sessions with OCD-trained therapists and 24/7 in-app support between sessions, using exposure and response prevention (ERP) therapy.

Digital HealthHealthtechMental HealthChicago, US

LARRY TRUSKY(Executive Officer)inStephen Smith(Cofounder)in

BoardGLEN TULLMAN(Director)in

Co-investors7wire VenturesChicago VenturesCorewell Health VenturesKaiser Permanente VenturesLongitude CapitalMeridian Street Capital+3 more

Paradigm Healthparadigmhealth.aiinJan 2021

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSColumbus, US

Kent Thoelke(Founder)inJonathan Hirsch(Chief Strategy and Growth Officer)Jay Trepanier(Chief Financial Officer)inElijah Meerson(Chief Technology Officer)inMichelle Lee(Chief Operating Officer)in

Co-investorsARCH Venture PartnersGeneral CatalystGV (Google Ventures)Lux CapitalJobsOhio VenturesMagnetic Ventures+2 more

Verve Therapeuticsvervetx.comJan 2021

Cambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.

BiotechCambridge, US

Andrew Ashe(Executive Officer)Sekar Kathiresan(Founder)inAndrew Bellinger(Executive Officer)Kiran Musunuru(Founder)

BoardJohn Evans(Director)Anthony Philippakis(Director)in

Co-investorsARCH Venture PartnersGV (Google Ventures)RA CapitalvenBio PartnersWellington ManagementCasdin Capital+3 more

well beamwell-beam.comSeries A · Oct 2021 · $10M

WellBeam offers an EMR-integrated solution that connects acute and post-acute care providers, letting physicians and advanced practice providers authorize home health orders, respond to clinician concerns, and manage patient status after discharge.

Digital HealthHealthtechSaaSPalo Alto, US

Amee Devani(CEO & Co-Founder)Pascal Odek(CTO & Co-Founder)James Huie(Executive Officer)

BoardJon Lim(Director)in

Co-investorsOncology VenturesUlu Ventures

Whatfixwhatfix.comin𝕏Sep 2021 · $32M

Whatfix builds a digital adoption platform that delivers in-app, contextual guidance, self-service support, and usage analytics on top of enterprise software such as ERP and CRM systems.

Enterprise SoftwareFuture of WorkSaaSBengaluru, IN

Khadim Batti(Founder)inVara Kumar Namburu(Founder)inAmit KKS(Chief Financial Officer)

Co-investorsWarburg PincusEight Roads VenturesHelion Venture PartnersCisco InvestmentsGSF AcceleratorPeak XV Partners+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Basecamp BioEmbark Veterinary, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.